Core Viewpoint - The company has decided to extend the implementation period for certain fundraising investment projects to optimize resource allocation and improve the efficiency of fundraising usage, aligning with its long-term development strategy [5]. Group 1: Fundraising Project Overview - The company raised a total of RMB 276,849.25 million through its initial public offering, with a share price of RMB 50.88 per share for 60 million shares [1]. - The total investment for the fundraising projects is RMB 778,506,100, with the company having excess funds of RMB 198,998.64 million after accounting for project needs [2]. Group 2: Extension of Implementation Period - The company plans to extend the implementation period for the "Information Management System Construction Project" from October 28, 2025, to December 31, 2027, to meet growing business needs and enhance patient experience [4]. - The project involves a total investment of RMB 20,386.80 million, fully funded by the raised capital, and includes components such as remote consultation systems and electronic medical records [4]. Group 3: Impact of the Extension - The decision to extend the project timeline is based on the company's future development plans and the actual progress of the fundraising projects, ensuring no adverse effects on project implementation or shareholder interests [5]. - The extension does not involve changes to the total investment amount, the amount of raised funds allocated, or the implementation methods of the projects [5]. Group 4: Decision-Making Process and Verification - The board of directors and the supervisory board approved the extension on August 21, 2025, within the board's authority, eliminating the need for shareholder approval [5]. - The sponsoring institution has verified that the extension complies with relevant regulations and does not alter the intended use of the raised funds [5].
华厦眼科: 中国国际金融股份有限公司关于华厦眼科医院集团股份有限公司部分募集资金投资项目延长实施期限的核查意见